
Researchers are developing a “once-in-a-generation” jab that could “cure” genetic heart conditions that cause sudden death.
Scientists say they hope that within just a few years a ‘cure’ injection that can be delivered to patients as a jab in the arm will be available.

BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
You can unsubscribe any time. By subscribing you agree to our Terms of Use
Sky News reports: An international team of researchers is developing the first cures for inherited heart muscle diseases by rewriting DNA with the aim of editing or silencing faulty genes.
Latest Videos
WEF Declares 'We Just Don’t Need The Vast Majority of You'
REVEALED: Biden’s IRS In Training To Carry Out Armed Raids on Suburban Homes
Anne Heche Was About To Expose Hollywood Pedophile Ring Before She Died
Operation Mockingbird: MSM Caught Reading EXACT Same Script About FBI’s Trump Raid
How Rockefeller Founded Big Pharma And Waged War On Natural Cures
Bombshell Evidence PROVES Justin Trudeau Is Fidel Castro’s Son
The Global Elites Are Normalizing Pedophilia
Uri Geller Threatens To Nuke Russia Using Just His Psychic Powers
UN Declares Conspiracy Theorists "Public Enemy no.1"
They have been awarded £30m by the British Heart Foundation (BHF) to fund their research.
The hope is that within just a few years a “cure” injection can be delivered to patients as a jab in the arm, and could be used to prevent illness in family members who carry the same faulty gene.
Inherited heart muscle conditions are driven by different abnormalities in the heart but can cause sudden death or progressive heart failure.
Every week in the UK, 12 people under the age of 35 die of an undiagnosed heart condition, very often caused by an inherited heart muscle disease, also known as genetic cardiomyopathy.
All those with genetic cardiomyopathies have a 50-50 risk of passing faulty genes on to each of their children and, often, several members of the same family develop heart failure, need a heart transplant, or die at a young age.
Professor Hugh Watkins, from the University of Oxford and lead investigator of the CureHeart project, said cardiomyopathies are “really common” and affect one person in every 250.
“There will be one or two in every school,” he told a briefing. “Every GP surgery will have several patients with these conditions, but there’s quite a range of severity.”
He said not all patients would require the new therapy being proposed, but “a very large number” would benefit.
He added: “This is our once-in-generation opportunity to relieve families of the constant worry of sudden death, heart failure and potential need for a heart transplant.
“After 30 years of research, we have discovered many of the genes and specific genetic faults responsible for different cardiomyopathies, and how they work. We believe that we will have a gene therapy ready to start testing in clinical trials in the next five years.”
Niamh Harris
Latest posts by Niamh Harris (see all)
- Over 100,000 ‘Digital First Responders’ Recruited By UN To Push Establishment Covid Narrative - August 19, 2022
- Yale Professor Blasted After Saying She Helps Kids As Young As 3 On Their ‘Gender Journey’ - August 19, 2022
- Tony Blair Wants Face Masks To Be Made Mandatory Again This Winter - August 19, 2022